Johnson & Johnson (JNJ) Restructuring Costs (2010 - 2026)
Johnson & Johnson's (JNJ) quarterly Restructuring Costs came in at $34.0 million in Q2 2026, down 46.88% year-over-year from $64.0 million in Q2 2025, and up 6.25% quarter-over-quarter from $32.0 million in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Restructuring Costs (2010 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Restructuring Costs across 13 years of filings, most recently posting $34.0 million for Q2 2026.
- In Q2 2026, Restructuring Costs fell 46.88% year-over-year to $34.0 million; the TTM figure through Jun 2026 stood at $213.0 million (up 29.88% YoY), while the FY2025 annual figure was $228.0 million, down 2.56% from the prior year.
- Restructuring Costs came in at $34.0 million for Q2 2026 at Johnson & Johnson, up from $32.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $164.0 million in Q1 2024 to a low of -$13.0 million in Q2 2024.
- Average Restructuring Costs over 5 years is $74.6 million, with a median of $64.5 million recorded in 2022.
- Year-over-year, Restructuring Costs slumped 108.97% in 2024 and surged 592.31% in 2025.
- Over 5 years, Restructuring Costs stood at $65.0 million in 2022, then retreated by 13.85% to $56.0 million in 2023, then declined by 25.0% to $42.0 million in 2024, then soared by 100.0% to $84.0 million in 2025, then sank by 59.52% to $34.0 million in 2026.
- Per Business Quant data, the three most recent Restructuring Costs figures were $34.0 million in Q2 2026, $32.0 million in Q1 2026, and $84.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 34.00 Mn |
| Mar 29, 2026 | 32.00 Mn |
| Dec 28, 2025 | 84.00 Mn |
| Sep 28, 2025 | 63.00 Mn |
| Jun 29, 2025 | 64.00 Mn |
| Mar 30, 2025 | 17.00 Mn |
| Dec 29, 2024 | 42.00 Mn |
| Sep 29, 2024 | 41.00 Mn |
| Jun 30, 2024 | -13.00 Mn |
| Mar 31, 2024 | 164.00 Mn |
| Dec 31, 2023 | 56.00 Mn |
| Oct 1, 2023 | 158.00 Mn |
| Jul 2, 2023 | 145.00 Mn |
| Apr 2, 2023 | 130.00 Mn |
| Jan 1, 2023 | 106.00 Mn |
| Oct 2, 2022 | 65.00 Mn |
| Jul 3, 2022 | 85.00 Mn |
| Apr 3, 2022 | 70.00 Mn |
| Oct 3, 2021 | 60.00 Mn |
| Jul 4, 2021 | 56.00 Mn |